Down-regulation of miR-133a contributes to up-regulation of Rhoa in bronchial smooth muscle cells.

RATIONALE Augmented bronchial smooth muscle (BSM) contraction is one of the causes of bronchial hyperresponsiveness. The protein RhoA and its downstream pathways have now been proposed as a new target for asthma therapy. MicroRNAs (miRNAs) play important roles in normal and diseased cell functions, and a contribution of miR-133 to RhoA expression has been suggested in cardiomyocytes. OBJECTIVES To make clear the mechanism(s) of up-regulation of RhoA observed in the BSMs of experimental asthma, the role of miR-133a in RhoA expression was tested. METHODS Total proteins and RNAs (containing miRNAs) were extracted from cultured human BSM cells (hBSMCs) that were treated with antagomirs and/or IL-13, and bronchial tissues of BALB/c mice that were sensitized and repeatedly challenged with ovalbumin. RhoA protein and miR-133a were detected by immunoblotting and quantified real-time reverse transcriptase-polymerase chain reaction, respectively. MEASUREMENTS AND MAIN RESULTS In hBSMCs, an up-regulation of RhoA was observed when the function of endogenous miR-133a was inhibited by its antagomir. Treatment of hBSMCs with IL-13 caused an up-regulation of RhoA and a down-regulation of miR-133a. In bronchial tissues of the repeatedly ovalbumin-challenged mice, a significant increase in RhoA was observed. Interestingly, the level of miR-133a was significantly decreased in BSMs of the challenged mice. CONCLUSIONS These findings suggest that RhoA expression is negatively regulated by miR-133a in BSMs. IL-13 might, at least in part, contribute to the reduction of miR-133a.

[1]  S. Kuromitsu,et al.  Synthesis and evaluation of 2-{[2-(4-hydroxyphenyl)-ethyl]amino}pyrimidine-5-carboxamide derivatives as novel STAT6 inhibitors. , 2007, Bioorganic & medicinal chemistry.

[2]  S. Hwang,et al.  Altered MicroRNA Expression in Cervical Carcinomas , 2008, Clinical Cancer Research.

[3]  Avrum Spira,et al.  MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium , 2009, Proceedings of the National Academy of Sciences.

[4]  Stijn van Dongen,et al.  miRBase: tools for microRNA genomics , 2007, Nucleic Acids Res..

[5]  H. Sakai,et al.  Hyperresponsiveness of bronchial but not tracheal smooth muscle in a murine model of allergic bronchial asthma , 2004, Inflammation Research.

[6]  R. Duisters,et al.  MIRNA-133 AND MIRNA-30 REGULATE CONNECTIVE TISSUE GROWTH FACTOR: IMPLICATIONS FOR A ROLE OF MIRNAS IN MYOCARDIAL MATRIX REMODELING , 2013 .

[7]  Hiroaki Kume,et al.  RhoA/Rho-kinase as a therapeutic target in asthma. , 2008, Current medicinal chemistry.

[8]  Y. Tanaka,et al.  Effect of an orally active Th1/Th2 balance modulator, M50367, on IgE production, eosinophilia, and airway hyperresponsiveness in mice. , 1999, Journal of immunology.

[9]  A. Halayko,et al.  Rho-kinase as a drug target for the treatment of airway hyperresponsiveness in allergic asthma , 2007 .

[10]  H. Sakai,et al.  Interleukin-13 augments bronchial smooth muscle contractility with an up-regulation of RhoA protein. , 2009, American journal of respiratory cell and molecular biology.

[11]  S. Roscioni,et al.  Monomeric G-proteins as signal transducers in airway physiology and pathophysiology. , 2008, Cellular signalling.

[12]  S. Miyamoto,et al.  Augmented acetylcholine‐induced, Rho‐mediated Ca2+ sensitization of bronchial smooth muscle contraction in antigen‐induced airway hyperresponsive rats , 1999, British journal of pharmacology.

[13]  J. Mattes,et al.  Discovery, biology and therapeutic potential of RNA interference, microRNA and antagomirs. , 2008, Pharmacology & therapeutics.

[14]  V. Ambros.  The functions of animal microRNAs , 2004, Nature.

[15]  R. Schellenberg,et al.  Structural and functional changes in the airway smooth muscle of asthmatic subjects. , 1998, American journal of respiratory and critical care medicine.

[16]  Mark M Perry,et al.  Maternally imprinted microRNAs are differentially expressed during mouse and human lung development , 2007, Developmental dynamics : an official publication of the American Association of Anatomists.

[17]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[18]  Anton J. Enright,et al.  Requirement of bic/microRNA-155 for Normal Immune Function , 2007, Science.

[19]  Thomas D. Schmittgen,et al.  Integrating the MicroRNome into the study of lung disease. , 2009, American journal of respiratory and critical care medicine.

[20]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[21]  A. Somlyo,et al.  Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. , 2003, Physiological reviews.

[22]  R. Panettieri,et al.  Modulation of calcium homeostasis as a mechanism for altering smooth muscle responsiveness in asthma , 2002, Current opinion in allergy and clinical immunology.

[23]  Y. Chiba,et al.  The role of RhoA-mediated Ca2+ sensitization of bronchial smooth muscle contraction in airway hyperresponsiveness. , 2004, Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi.

[24]  Zissimos Mourelatos,et al.  MicroRNAs: Biogenesis and Molecular Functions , 2008, Brain pathology.

[25]  A. Pivarcsi,et al.  Advances in microRNAs: implications for immunity and inflammatory diseases , 2008, Journal of cellular and molecular medicine.

[26]  C. Croce,et al.  MicroRNA-133 controls cardiac hypertrophy , 2007, Nature Medicine.

[27]  R. Giegerich,et al.  Fast and effective prediction of microRNA/target duplexes. , 2004, RNA.

[28]  I. Pavord,et al.  Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis. , 2004, The Journal of allergy and clinical immunology.

[29]  I. Pavord,et al.  Increased sputum and bronchial biopsy IL-13 expression in severe asthma. , 2008, The Journal of allergy and clinical immunology.

[30]  H. Sakai,et al.  Involvement of RhoA-mediated Ca2+ sensitization in antigen-induced bronchial smooth muscle hyperresponsiveness in mice , 2005, Respiratory research.

[31]  A. Halayko,et al.  Rho kinase inhibitors: a novel therapeutical intervention in asthma? , 2008, European journal of pharmacology.

[32]  Y. Chiba,et al.  A novel STAT6 inhibitor AS1517499 ameliorates antigen-induced bronchial hypercontractility in mice. , 2009, American journal of respiratory cell and molecular biology.

[33]  P. Foster,et al.  Regulation of microRNA by antagomirs: a new class of pharmacological antagonists for the specific regulation of gene function? , 2007, American journal of respiratory cell and molecular biology.

[34]  Michael Detmar,et al.  Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. , 2008, Arthritis and rheumatism.

[35]  K. Dobashi,et al.  Relaxation of contracted rabbit tracheal and human bronchial smooth muscle by Y-27632 through inhibition of Ca2+ sensitization. , 1999, American journal of respiratory cell and molecular biology.

[36]  J. Martin,et al.  The contribution of airway smooth muscle to airway narrowing and airway hyperresponsiveness in disease. , 2000, The European respiratory journal.

[37]  François Chevenet,et al.  OligoHeatMap (OHM): an online tool to estimate and display hybridizations of oligonucleotides onto DNA sequences , 2008, Nucleic Acids Res..

[38]  S. Ho,et al.  Environmental epigenetics and asthma: current concepts and call for studies. , 2008, American journal of respiratory and critical care medicine.

[39]  Stephen P Finn,et al.  Potential role of miR-9 and miR-223 in recurrent ovarian cancer , 2008, Molecular Cancer.